SMT C1100: Clinical Trials

3 trials of SMT C1100, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Terminated 1

Follow SMT C1100: new trials by email Literature Review of SMT C1100 trials Research Report on SMT C1100

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Proof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular Dystrophy (DMD)
Ezutromid - Duchenne Muscular Dystrophy
Phase 2TerminatedSummit Therapeutics432016-06-012020-01-02
Modified Diet Trial: A Study of SMT C1100 in Paediatric Patients With DMD Who Follow a Balanced Diet
SMT C1100 - Muscular Dystrophy, Duchenne
Phase 1CompletedSummit Therapeutics122015-02-012015-08-26
A Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD)
SMT C1100 - Duchenne Muscular Dystrophy
Phase 1CompletedSummit Therapeutics122013-11-012014-08-27

Conditions studied

Muscular Dystrophy, Duchenne (3)  ·  Muscular Dystrophies (1)

Sponsors

Summit Therapeutics (3)

Countries

United Kingdom (3)  ·  United States (1)

Top investigators

Franceso Muntoni, MD (1)  ·  Helen Roper, MD (1)  ·  Imelda Hughes, MD (1)  ·  Stefan Spinty, MD (1)

Results publications

PMID 27055247

NIH funding

2015 (1)